President Donald Trump's proposed tariffs on pharmaceuticals could lead to higher prices, higher insurance premiums, and even drug shortages, experts say.

Novartis AG announced disappointing sales for a key psoriasis drug and the looming retirement of its respected finance chief, ...

Conversations with the Trump administration on its “most favored nation” policy have been productive, the executive said ...

President Trump on Wednesday said he would be sending letters to over 150 countries as he plans a barrage of duties to take ...

Novartis ( NYSE: NVS) CEO Vas Narasimhan said the company has built up its U.S. inventories to help mitigate the impact of ...

Novartis (NVS) raised its full-year profit outlook thanks to strong demand for some of its key drugs. Novartis CEO Vas ...

Novartis stock fell early Thursday after the drugmaker reported light sales of Cosentyx, one of its biggest moneymakers.

Rather than continuing to retaliate with tariffs of its own, the Canadian government has begun to confess that such a tactic ...

"Halfway through the year, we delivered high single-digit organic sales growth, double-digit EPS growth, significantly ...

In its Q2 earnings call Thursday, Novartis said it is moving quickly to reshore its drug manufacturing operations, but CEO ...

American consumers of Korean cosmetics and skin-care products are bulk buying, as President Trump threatens 25 percent tariffs on imports.

In April, Trump announced a 25% tariff on U.S. imports from South Korea as part of his broader “Liberation Day” trade package ...